Methylene Blue and the Retina: What the Optic Nerve Research Shows
Four animal and cell culture studies report methylene blue protects retinal ganglion cells in optic neuropathy models. There are no human trials in glaucoma or any other eye disease.
Four animal and cell culture studies report methylene blue protects retinal ganglion cells in optic neuropathy models. There are no human trials in glaucoma or any other eye disease.
Blood services use methylene blue plus visible light to inactivate viruses in donated plasma, then filter the dye out before transfusion. One of the largest-scale medical uses of the compound, and it says nothing about supplements.
Methylene blue chromoendoscopy stains intestinal-type tissue during endoscopy to target biopsies in Barrett esophagus. It is a diagnostic aid, not a treatment, and dye-free virtual chromoendoscopy largely overtook it.
Methylene blue mouth rinse has been studied for intractable oral mucositis pain in cancer patients across three clinical reports. The reported relief is substantial and none of the studies is placebo-controlled.
Methylene blue has been tested in bipolar disorder in controlled trials since the 1980s, including a 2017 randomized crossover study and a 2024 neuroimaging RCT. The serotonin syndrome risk is central to reading any of it.
Intradiscal methylene blue injection has been tested in humans for chronic discogenic low back pain, with a striking 2007 trial and a more measured 2016 multicenter series. It is a spinal procedure with no oral equivalent.
Methylene blue is a rescue option in refractory septic shock, not standard care. A multicenter randomized trial protocol published in 2024 shows the question is still open.
Vasoplegic syndrome after cardiac surgery is where methylene blue has its strongest randomized evidence, including a 2004 trial and a 2024 meta-analysis. It is an intravenous ICU rescue therapy, not a case for oral supplements.
Surgeons inject methylene blue into the breast to trace lymphatic drainage during cancer surgery. It works well, and at full strength it can also cause skin and fat necrosis. Dilution is the whole story.
Ifosfamide chemotherapy causes confusion, hallucinations, or coma in a minority of patients, and methylene blue is the most commonly used antidote. Here is what the evidence actually supports and where it stops.
A 2017 laboratory study drove years of anti-aging headlines about methylene blue. Here is what it tested, what it found, and the gap between that and a product claim.
Methylene blue was the first synthetic drug used in humans, against malaria in 1891. Modern randomized trials in West Africa have revisited it. Here is what they found.